CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Volume: 15, Issue: 7, Pages: 673 - 684
Published: Jun 1, 2016
Abstract
Summary null Background null Alzheimer's disease biomarkers are important for early diagnosis in routine clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's disease (Aβ42, T-tau, and P-tau) have been assessed in numerous studies, and several other Alzheimer's disease markers are emerging in the literature. However, there have been no comprehensive meta-analyses of their diagnostic performance. We...
Paper Details
Title
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Published Date
Jun 1, 2016
Volume
15
Issue
7
Pages
673 - 684
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.